# Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/updated-overall-survival-and-final-progression-free-survival-data-for-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tony Mok,D. Ross Camidge,Shirish M. Gadgeel,Rafael Rosell,Rafał Dziadziuszko,D.-W. Kim,M. Pérol,S.-H.I. Ou,Jin Seok Ahn,A. Shaw,Walter Bordogna,Vlatka Smoljanović,Magalie Hilton,Thorsten Ruf,Johannes Noé,Solange Peters |
| Citations | 699 |
| DOI | 10.1016/j.annonc.2020.04.478 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.annonc.2020.04.478 |
| OpenAlex ID | https://openalex.org/W3022131485 |
| PMID | 32418886 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Jin Seok Ahn](https://scholariq.org/researchers/jin-seok-ahn/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.